FDC Wins Approval for Ciprofloxacin Ophthalmic Solution
FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution.
FDC’s Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections.
The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.